Vidyya Medical News Service
Volume 5 Issue 74 Published - 14:00 UTC 08:00 EST 15-Mar-2003 Next Update - 14:00 UTC 08:00 EST 16-Mar-2003
little clear gif used for spacer

FDA approves first drug in new class of HIV treatments for HIV infected adults and children with advanced disease
The Food and Drug Administration (FDA) today announced the accelerated approval of Fuzeon (enfuvirtide) for use in combination with other anti-HIV medications to treat advanced HIV-1 infection in adults and children ages 6 years and older.  more

Prescribing information: Fuzeon
The approved labeling for Fuzeon warns physicians to carefully monitor patients for signs and symptoms of pneumonia. Although bacterial pneumonia was uncommon in clinical study participants, more patients treated with Fuzeon developed bacterial pneumonia than did patients who did not receive Fuzeon.  more


Information for patients: Fuzeon
Patients receiving Fuzeon are advised to seek medical evaluation immediately if they develop signs or symptoms suggestive of pneumonia such as cough with fever, rapid breathing and shortness of breath. In addition, Fuzeon can cause both serious systemic allergic reactions and local skin reactions at the site of injection.  more

FDA approves lower dose of prempro, a combination estrogen and progestin drug for postmenopausal women
FDA today approved a lower dose single tablet of Prempro, containing 0.45 estrogen and 1.5 progestin (medroxyprogesterone) to treat specific symptoms of menopause. A progestin is needed when a postmenopausal woman uses estrogen and has a uterus (womb) because estrogens may increase the risk of uterine problems and a progestin lowers the chance of having these problems.  more

CDC study finds colorectal cancer screening rates remain low
Although scientific evidence shows that more than one-third of deaths from colorectal cancer could be avoided if people aged 50 and older were screened regularly, Americanís screening rates remain low, CDC reported today.  more

little clear gif used for a space